Agent Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Cantai develops rationally designed bispecific antibodies that combine clinically validated mechanisms to treat patients with autoimmune disease.
BiotechHealthtechPhiladelpia, US
Errik Anderson(Executive Officer, Director)Ross Leimberg(Executive Officer, Director)
BoardJoshua Brandt(Director)Geeta Vemuri(Executive Officer, Director)in
Co-investors82VS
Jana Care offers a smartphone-enabled at-home blood testing system using its Aina device, paper test strips, and a mobile app to detect key biomarkers for chronic disease management.
Digital HealthHealthtechMedical DevicesWatertown, US
Sidhant Jena(Executive Officer, Director)Timothy Richards(Executive Officer)Richard Williams(Executive Officer)Anh Hoang-Lindsay(Executive Officer, Director)Michal Depa(Executive Officer, Director)
BoardEhsan Jabbarzadeh(Director)
Co-investorsFirst Avenue VenturesIAG Capital PartnersPatamar CapitalThe A-Team
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.